Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients

Seoul National University

Status: Completed

Conditions: Tuberculosis

Treatments: Other: Blood samplings

Study type: Observational

Funder types: Other

Identifiers

NCT01121068

monthly IGRA

Details and patient eligibility

About

Interferon gamma releasing assay(IGRA) is useful to diagnose latent tuberculosis. However,IGRA responses could show within-subject variability. We wanted to determine long-term IGRA variability in health-care workers who continuously expose to tuberculosis patients.

Full description

IGRA will be performed monthly in health-care workers with continuous exposure to tuberculosis patients for 1 year.

Enrollment: 49 patients

Sex: All

Ages: 20+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Health care workers who are continuously exposed to TB patients Age > 20 years

Exclusion criteria

• Pregnant Active TB Use of immunosuppressants

Trial design

49 participants in 1 patient group

Health care workers

Treatment:

Other: Blood samplings